Medifast (MED) Stock: Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 14, 2026

Net buying: insiders sold $226K and bought $1.5M on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: +$1.3M net
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about MED filings

Are insiders buying or selling MEDIFAST INC (MED) stock?

Net buying: insiders sold $226K and bought $1.5M of MED stock on the open market in the 90 days to Nov 14, 2026, according to SEC Form 4 filings. $226K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Kiai, Parsa (Director), who bought $1.5M. The latest filing was on Nov 6, 2026.

Which members of Congress have traded MED recently?

None. No member of Congress disclosed a MED trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this MED smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Filings could not be loaded.

19 funds hold a position and insiders have been net buying.

Questions about MED filings

Are insiders buying or selling MEDIFAST INC (MED) stock?

Which members of Congress have traded MED recently?

None. No member of Congress disclosed a MED trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this MED smart-money data?

Insiders

What insiders are doing

6 trades · 6 mo

Bought$1.5MSold$226K

Buys (2)

KP
Kiai Parsa
Dir · Nov 6
$9K
bought
KP
Kiai Parsa
Dir · Oct 30
$68K
bought
Signals like this: n=2459, 52% finished lower at D15, median -0.4% vs SPY +0.2%

Sells (1)

CD
Chard Daniel R
Dir · Oct 1
$226K
sold

2 more trades

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 2 trades

Unlock everything for $29/month

Unlock for $29/month

Reported Oct 26, 2026

Earnings came in 45.7% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Oct 26, 2026

Period ending

Sep 30, 2026

Earnings per share

-$0.19+45.71% beat

-$0.35 expected

Revenue

$72.0M

SEC filing

EPS: Yahoo Finance

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Oct 26, 2026	-$0.19est. -$0.35	+45.71%beat	$72.0MSEC filing	-19.4%from $89.4M
Jun 30, 2026Reported Aug 3, 2026	-$0.28est. -$0.65	+56.92%beat	$76.4MSEC filing	-27.6%from $105.6M
Mar 31, 2026Reported May 4, 2026	-$0.19est. -$0.52	+63.46%beat	$76.0MSEC filing	-34.3%from $115.7M
Dec 31, 2025Reported Feb 17, 2026	-$1.65est. -$0.82	-101.22%miss	$75.1MYahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 3, 2025	-$0.21est. -$0.36	+41.67%beat	$89.4MSEC filing	-36.2%from $140.2M
Jun 30, 2025Reported Aug 4, 2025	$0.22est. -$0.19	+$0.41beat	$105.6MSEC filing	-37.4%from $168.6M
Mar 31, 2025Reported Apr 28, 2025	-$0.07est. -$0.25	+72.00%beat	$115.7MSEC filing	-33.8%from $174.7M
Dec 31, 2024Reported Feb 18, 2025	$0.10est. $0.24	-58.75%miss	$602.5M · FYSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $13.08
High: $13.16
Low: $12.81
Prev close: $13.13
52-wk high: $13.63
52-wk low: $9.22
Mkt cap: $143.8M
ROE: -20.7%
Fwd P/E: 12.5x
Beta: 0.69
P/S: 0.5x
P/B: 0.8x
Profit margin: -13.6%
Op margin: -11.6%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -13.6%
Forward P/E: 12.48
Market cap: $144M

Valuation

P/S0.48
P/B0.81

Quality

Operating margin-11.6%
ROE-20.7%
ROA-8.6%

Growth

Beta0.69

Technicals

Price structure

This stock is in a strong uptrend.

Trend

Strong uptrend

100 / 100

RSI 14

63balanced

20D volatility

36%annualized

52-week range

$12.86

$9.22$13.63

20D support

$11.67recent floor

20D resistance

$13.63recent ceiling

Returns

5D +1.0%20D +6.6%60D +11.0%

Price vs moving averages

SMA20 +3.0%SMA50 +6.1%SMA200 +13.0%

Volume pace

1.09xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Oct 26, 2026

-$0.19est. -$0.35

+45.71%

$72.0MSEC filing

-19.4%from $89.4M

Jun 30, 2026Aug 3, 2026

-$0.28est. -$0.65

+56.92%

$76.4MSEC filing

-27.6%from $105.6M

Mar 31, 2026May 4, 2026

-$0.19est. -$0.52

+63.46%

$76.0MSEC filing

-34.3%from $115.7M

Dec 31, 2025Feb 17, 2026

-$1.65est. -$0.82

-101.22%

$75.1MYahoo Finance

No year-ago quarter

Sep 30, 2025Nov 3, 2025

-$0.21est. -$0.36

+41.67%

$89.4MSEC filing

-36.2%from $140.2M

Jun 30, 2025Aug 4, 2025

$0.22est. -$0.19

+$0.41

$105.6MSEC filing

-37.4%from $168.6M

Mar 31, 2025Apr 28, 2025

-$0.07est. -$0.25

+72.00%

$115.7MSEC filing

-33.8%from $174.7M

Dec 31, 2024Feb 18, 2025

$0.10est. $0.24

-58.75%

$602.5M · FYSEC filing

No year-ago quarter

MEDIFAST INC

Smart money at a glance

What do analysts expect?

Questions about MED filings

Questions about MED filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 45.7% above what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

MEDIFAST INC

Smart money at a glance

What do analysts expect?

Questions about MED filings

Questions about MED filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 45.7% above what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

MEDIFAST INC

Overview

Questions about MED filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

MEDIFAST INC

Overview

Questions about MED filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.